Beta test rollout. This site is in community QA — please send feature requests, bug reports and data corrections on the Feedback page or on GitHub.

Home
    Disclaimer
    5-MeO-MET molecular structure

    5-MeO-MET Stats & Data

    PubChem
    MW232.32
    FormulaC14H20N2O
    LogP1.9
    IUPACN-ethyl-2-(5-methoxy-1H-indol-3-yl)-N-methylethanamine
    InChIKeyAVECDEWGCOLCPZ-UHFFFAOYSA-N
    Chemical Class Substituted tryptamine
    Psychoactive Class Psychedelic

    Effect Profile

    Curated + 1 Reports
    Psychedelic 2.8

    Moderate body load with mild visuals, low headspace

    Visual Intensity×3
    4
    Headspace Depth×3
    2
    Auditory Effects×1
    0
    Body Load / Somatic Effects×1
    6

    Duration Timeline

    Bluelight
    Onset Comeup Peak Offset After Effects
    Oral
    10-45 minutes
    2.0-3.0 hours
    1.0-2.0 hours
    Smoked
    1-4 minutes
    1.0-2.0 hours

    Community Effects

    TripSit
    Negative
    body load

    Tolerance & Pharmacokinetics

    drugs.wiki

    Tolerance Decay

    Full tolerance 1h Half tolerance 10d Baseline ~14d

    Cross-Tolerances

    LSD
    Psilocybin
    Psilocin
    Mescaline
    DMT
    5-MeO-DMT
    2C-B
    2C-E

    Experience Report Analysis

    Erowid
    3 Reports
    1 Single-substance
    2020–2022 Date Range
    3 With Age Data

    Demographics

    Gender Distribution

    Too few reports for a chart: gender is known from 3 reports, and a split is drawn only from 20 reports or more. Counts are shown instead. Why 20?

    • Male 2 of 3
    • Not Specified 1 of 3

    Age Distribution

    Reports Over Time

    Real-World Dose Distribution

    62K Doses

    From 12 individual dose entries. Values above Q3 + 3×IQR are left out as outliers.

    Oral (n=9)

    Median: 25.0mg 25th: 16.0mg 75th: 49.0mg 90th: 49.0mg
    ← Back to 5-MeO-MET